TrialHub celebrates five years of increasing access to trials for underserved populations including individuals diagnosed with melanoma, rare cancers and those living in outer metropolitan, regional, rural and remote areas.

We are proud to announce the successful completion of 24-months of follow-up for the IMAGE trial, a landmark study evaluating the role of Melanoma Surveillance Photography (MSP) in improving early detection of melanoma among high and ultra-high-risk patients.

Leading skin care brand Avène has raised nearly $39,000 to support clinical trials led by Melanoma and Skin Cancer Trials.